Highly functional and prolonged germinal center T follicular helper cell responses are associated with enhanced neutralizing antibody development.

Saved in:
Bibliographic Details
Title: Highly functional and prolonged germinal center T follicular helper cell responses are associated with enhanced neutralizing antibody development.
Authors: Marina-Zárate E; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA., Sutton HJ; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA., Lopez PG; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA., Altheide TK; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA., Bick M; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA., Burton I; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA., Ben-Akiva E; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Kaczmarek Michaels K; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA., Hyacinth K; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA., Healy BS; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA., Lim D; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA., Hangartner L; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA., Burton DR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; IAVI Neutralizing Antibody Center (NAC), The Scripps Research Institute, La Jolla, San Diego, CA, USA., Carnathan DG; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA., Silvestri G; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA., Schief WR; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA., Irvine DJ; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Crotty S; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, San Diego, CA, USA. Electronic address: shane@lji.org.
Source: Immunity [Immunity] 2025 Dec 09; Vol. 58 (12), pp. 3094-3112.e7. Date of Electronic Publication: 2025 Nov 07.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41205611
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Highly functional and prolonged germinal center T follicular helper cell responses are associated with enhanced neutralizing antibody development.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Marina-Zárate+E%22">Marina-Zárate E</searchLink>; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Sutton+HJ%22">Sutton HJ</searchLink>; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lopez+PG%22">Lopez PG</searchLink>; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Altheide+TK%22">Altheide TK</searchLink>; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bick+M%22">Bick M</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Burton+I%22">Burton I</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ben-Akiva+E%22">Ben-Akiva E</searchLink>; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kaczmarek+Michaels+K%22">Kaczmarek Michaels K</searchLink>; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hyacinth+K%22">Hyacinth K</searchLink>; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Healy+BS%22">Healy BS</searchLink>; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Lim+D%22">Lim D</searchLink>; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Hangartner+L%22">Hangartner L</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Burton+DR%22">Burton DR</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; IAVI Neutralizing Antibody Center (NAC), The Scripps Research Institute, La Jolla, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Carnathan+DG%22">Carnathan DG</searchLink>; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Silvestri+G%22">Silvestri G</searchLink>; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; Emory National Primate Research Center and Emory Vaccine Center, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Schief+WR%22">Schief WR</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Irvine+DJ%22">Irvine DJ</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, San Diego, CA, USA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA.<br /><searchLink fieldCode="AU" term="%22Crotty+S%22">Crotty S</searchLink>; Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, San Diego, CA, USA; Consortium for HIV Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, San Diego, CA, USA; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego (UCSD), La Jolla, San Diego, CA, USA. Electronic address: shane@lji.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229432918%22">Immunity</searchLink> [Immunity] 2025 Dec 09; Vol. 58 (12), pp. 3094-3112.e7. <i>Date of Electronic Publication: </i>2025 Nov 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9432918 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-4180 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210747613%22">10747613 </searchLink><i>NLM ISO Abbreviation: </i>Immunity <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41205611
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.immuni.2025.10.008
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 3094
    Titles:
      – TitleFull: Highly functional and prolonged germinal center T follicular helper cell responses are associated with enhanced neutralizing antibody development.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Marina-Zárate E
      – PersonEntity:
          Name:
            NameFull: Sutton HJ
      – PersonEntity:
          Name:
            NameFull: Lopez PG
      – PersonEntity:
          Name:
            NameFull: Altheide TK
      – PersonEntity:
          Name:
            NameFull: Bick M
      – PersonEntity:
          Name:
            NameFull: Burton I
      – PersonEntity:
          Name:
            NameFull: Ben-Akiva E
      – PersonEntity:
          Name:
            NameFull: Kaczmarek Michaels K
      – PersonEntity:
          Name:
            NameFull: Hyacinth K
      – PersonEntity:
          Name:
            NameFull: Healy BS
      – PersonEntity:
          Name:
            NameFull: Lim D
      – PersonEntity:
          Name:
            NameFull: Hangartner L
      – PersonEntity:
          Name:
            NameFull: Burton DR
      – PersonEntity:
          Name:
            NameFull: Carnathan DG
      – PersonEntity:
          Name:
            NameFull: Silvestri G
      – PersonEntity:
          Name:
            NameFull: Schief WR
      – PersonEntity:
          Name:
            NameFull: Irvine DJ
      – PersonEntity:
          Name:
            NameFull: Crotty S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 12
              Text: 2025 Dec 09
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1097-4180
          Numbering:
            – Type: volume
              Value: 58
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Immunity
              Type: main
ResultId 1